By Denny Jacob Armata Pharmaceuticals shares rose 13% to $4.92 after narrowing its loss in the latest quarter. The stock has almost quadrupled on the year..
Armata Pharmaceuticals, Inc (NYSEAMERICAN:ARMP) Short Interest Up 688 3% in July wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Get Free Report) is scheduled to issue its quarterly earnings data on Wednesday, August 9th. Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Get Free Report) last posted its quarterly earnings data on Thursday, May 11th. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.11). The […]
Received GSK royalties of $65.7 million, net product revenues of $15.7 million and license revenue of $3.0 million in the second quarter of 2023
Received FDA approval for XACDURO® for treatment of.